查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1829620

2025年全球生物製藥管市場報告

Biopharmaceutical Tubing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，生物製藥導管市場快速擴張，市場規模從2024年的43.2億美元成長至2025年的47.9億美元，複合年成長率為10.9%。預測期內的成長歸因於微創手術需求的不斷成長、老年人口的成長、超高純度和耐腐蝕系統需求的不斷成長，以及診斷設備和藥物輸送系統需求的激增。

預計未來幾年生物製藥導管市場將快速成長，到2029年將達到73.1億美元，年複合成長率（CAGR）為11.2%。預測期內的成長可歸因於生物製藥產量的不斷成長、日益嚴格的法規和政策、對高效無污染生物製程日益成長的需求、安全措施的加強以及製藥研發的不斷成長。預測期內的主要趨勢包括一次性系統的進步、導管材料的創新、客製化導管解決方案的進步以及導管設計的創新。

生物製藥導管是指用於生物製藥生產和處理的專用導管。其設計符合嚴格的無菌性、生物相容性和精密度標準，可在整個生產和給藥過程中安全有效地物料輸送。

生物製藥導管市場的主要產品包括矽膠導管、聚氯乙烯(PVC) 導管、聚烯導管和熱可塑性橡膠導管。矽膠生物製藥導管以其柔韌性和高純度而聞名，由專為生物製藥行業設計的矽橡膠製成。這些導管的開發流程包括擠出和硫化成型，其應用範圍廣泛，包括製藥、醫療設備和研發領域。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供生物製藥導管市場統計數據，包括全球市場規模、區域佔有率、生物製藥導管市場佔有率的競爭對手、詳細的生物製藥導管市場細分、市場趨勢以及行業商機。這些生物製藥導管市場研究報告透過對產業現狀和未來狀況的詳細分析，為您提供全面的展望。

未來五年的預測成長率為11.2%，較我們先前對該市場的預測略有下降0.1%。這一下降主要源自於美國與其他國家之間關稅的影響。美國將透過提高對比利時和新加坡鉑金固化矽膠管和多層聚合物管的關稅直接受到影響，這可能會增加製藥和生物加工應用的成本。此外，由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響，這項影響也將更加廣泛。

個人化醫療的日益普及預計將推動生物製藥導管市場的擴張。個人化醫療是一種根據每個患者的個人特徵來客製化醫療保健決策、實踐、介入和治療的方法。隨著基因研究的進步，可以根據個人的基因特徵、生活方式和特定健康狀況制定治療策略，這種方法越來越受歡迎。生物製藥導管在個人化醫療中發揮關鍵作用，確保輸液準確、無菌、可靠。例如，美國會員組織個人化醫療聯盟報告稱，2022 年核准了12 種新的個人化藥物，約佔新核准治療方法的 34%。與前幾年相比，這是一個顯著的成長，凸顯了個人化醫療在推動生物製藥導管市場成長方面的作用。

生物製藥導管市場的主要企業正在透過下一代解決方案（例如生物可吸收導管）來改善其產品，以提高先進生物製藥應用中的性能、無菌性和流體處理能力。生物可吸收導管由可逐漸被人體分解和吸收的材料製成，且無需在使用後取出。例如，2023 年 9 月，美國先進聚合物解決方案提供商 Zeus 推出了 Absorv XSE定向導管，這是一款專為生物可吸收血管支架 (BRS) 設計的下一代生物可吸收產品。這項創新使醫療設備製造商能夠探索 BRS 在冠狀動脈疾病治療之外的應用，並有可能在各種手術中取代金屬支架。新型導管改善了壁厚和尺寸均勻性，提高了雷射切割製程的效率，並使得支架更加方便用戶使用。

2024年2月，瑞典投資管理公司EQT Private 股權以34億美元收購了Zeus。此次收購旨在透過投資提升產能、研發和卓越營運（尤其是在醫用導管技術領域）來支持Zeus的成長。 Zeus是一家總部位於美國的製造商，以精密聚合物擠出和客製化導管而聞名。

生物製藥導管市場包括聚四氟乙烯 (PTFE) 導管、乙烯-醋酸乙烯酯 (EVA) 導管和橡膠導管的銷售。此市場的價值是指“出廠價”，即產品製造商或生產商向其他營業單位（包括下游製造商、批發商、經銷商）或直接向最終客戶銷售的產品價值。該市場的產品價值還包括產品製造商提供的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球生物製藥管：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球生物製藥管道市場：成長率分析
  • 全球生物製藥管道市場表現：規模與成長，2019-2024
  • 全球生物製藥導管市場預測：規模與成長，2024-2029年，2034年
  • 全球生物製藥導管：總目標市場（TAM）

第6章 市場細分

  • 全球生物製藥導管市場：依產品、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 矽膠管
  • 聚氯乙烯（PVC）管材
  • 聚烯管
  • 熱可塑性橡膠體管
  • 全球生物製藥導管市場：按製造流程、實際結果和預測，2019-2024 年、2024-2029 年、2034 年
  • 擠壓
  • 硫化
  • 其他製造程序
  • 全球生物製藥導管市場：按應用、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 製藥
  • 醫療設備
  • 研究與開發
  • 其他用途
  • 全球生物製藥管市場：矽膠管細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 醫用級矽膠管
  • 鉑金固化矽膠管
  • 過氧化物固化矽膠管
  • 全球生物製藥管市場：聚氯乙烯(PVC) 管細分（按類型）、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 透明PVC管
  • 不含 DEHP 的 PVC 管
  • 軟PVC管
  • 全球生物製藥管道市場：聚烯管道細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 交聯聚烯管
  • 低密度聚乙烯管
  • 高密度聚苯乙烯管
  • 全球生物製藥管道市場：熱可塑性橡膠管道細分（按類型）、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 醫療級TPE管
  • 彈性體TPE管
  • 生物相容性TPE管

第7章 區域和國家分析

  • 全球生物製藥導管市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球生物製藥導管市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 生物製藥管線市場：競爭格局
  • 生物製藥管道市場：公司簡介
    • Compagnie de Saint-Gobain SA Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • GE HealthCare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Parker Hannifin Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • DuPont de Nemours Inc.
  • Freudenberg Group
  • Medline Industries LP
  • Avantor Inc.
  • Alfa Laval AB
  • REHAU Group
  • WL Gore & Associates Inc.
  • Sartorius AG
  • Elkem ASA
  • Trelleborg AB
  • Bio-Rad Laboratories Inc.
  • Tekni-Plex Inc.
  • Pall Corporation
  • Zeus Company Inc.
  • Watson-Marlow Ltd.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年生物製藥管線市場：提供新機會的國家
  • 2029年生物製藥管道市場：細分市場將帶來新機會
  • 2029年生物製藥管道市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r29615u

Biopharmaceutical tubing refers to specialized tubing used in the production and handling of biopharmaceutical products. It is engineered to meet rigorous standards for sterility, biocompatibility, and precision to ensure the safe and effective handling of sensitive materials throughout both manufacturing and administration processes.

The main products in the biopharmaceutical tubing market include silicone tubing, polyvinyl chloride (PVC) tubing, polyolefin tubing, and thermoplastic elastomer tubing. Silicone biopharmaceutical tubing is known for its flexibility and high purity, made from silicone rubber and specifically designed for use in the biopharmaceutical industry. Manufacturing processes for these tubes include extrusion and vulcanization, with applications spanning pharmaceuticals, medical devices, research and development, and other areas.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The biopharmaceutical tubing market research report is one of a series of new reports from The Business Research Company that provides biopharmaceutical tubing market statistics, including the biopharmaceutical tubing industry global market size, regional shares, competitors with biopharmaceutical tubing market share, detailed biopharmaceutical tubing market segments, market trends, and opportunities, and any further data you may need to thrive in the biopharmaceutical tubing industry. These biopharmaceutical tubing market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The biopharmaceutical tubing market size has grown rapidly in recent years. It will grow from $4.32 billion in 2024 to $4.79 billion in 2025 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to rise in demand for minimally invasive procedures, increase in elderly population, rise in demand for ultra- pure and corrosion- resistant system, and surge in demand for diagnostic equipment and drug delivery systems.

The biopharmaceutical tubing market size is expected to see rapid growth in the next few years. It will grow to $7.31 billion in 2029 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to increasing biopharmaceutical production, stricter regulation policies, rising need for efficient and contamination-free bioprocessing, rising safety measures, and growing pharmaceutical R&D. Major trends in the forecast period include advancements in single-use systems, innovations in tubing materials, advancements in customized tubing solutions, and innovation in tubing design.

The forecast of 11.2% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through higher tariffs on platinum-cured silicone and multi-layer polymer tubing from Belgium and Singapore, increasing expenses for drug manufacturing and bioprocessing applications.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing use of personalized medicines is expected to drive the expansion of the biopharmaceutical tubing market. Personalized medicine is an approach that customizes healthcare decisions, practices, interventions, and treatments to match the individual characteristics of each patient. This approach is gaining traction due to advancements in genetic research, which allow for treatment strategies tailored to an individual's genetic profile, lifestyle, and specific health conditions. Biopharmaceutical tubing plays a crucial role in personalized medicine by ensuring precise, sterile, and reliable fluid transfer, which is essential for delivering customized treatments and therapies. For instance, in 2022, the Personalized Medicine Coalition, a US-based membership organization, reported the approval of 12 new personalized medicines, representing about 34% of all newly approved therapies. This marks a significant increase compared to previous years, highlighting the role of personalized medicines in driving the growth of the biopharmaceutical tubing market.

Key players in the biopharmaceutical tubing market are advancing their product offerings with next-generation solutions, such as bioabsorbable tubing, to enhance performance, sterility, and fluid handling for advanced biopharmaceutical applications. Bioabsorbable tubing is made from materials that gradually break down and are absorbed by the body, eliminating the need for removal after use. For example, in September 2023, Zeus Company Inc., a US-based provider of advanced polymer solutions, introduced the Absorv XSE-oriented tubing, a next-generation bioabsorbable product designed for bioresorbable vascular scaffolds (BRS). This innovation allows medical device manufacturers to explore BRS applications beyond treating coronary artery disease and potentially replace metallic stents in various procedures. The new tubing offers improved wall thickness and sizing uniformity, enhancing efficiency during laser cutting processes and resulting in more usable scaffolds.

In February 2024, EQT Private Equity, a Sweden-based investment management firm, acquired Zeus Company Inc. for $3.4 billion. This acquisition aims to support Zeus's growth by investing in additional production capacity, research and development, and operational excellence, particularly in medical tubing technology. Zeus Company Inc. is a US-based manufacturer known for precision polymer extrusions and custom tubing.

Major companies operating in the biopharmaceutical tubing market are Compagnie de Saint-Gobain S.A., Thermo Fisher Scientific Inc., Merck KGaA, GE HealthCare Technologies Inc., Parker Hannifin Corporation, DuPont de Nemours Inc., Freudenberg Group, Medline Industries LP, Avantor Inc., Alfa Laval AB, REHAU Group, W. L. Gore & Associates Inc., Sartorius AG, Elkem ASA, Trelleborg AB, Bio-Rad Laboratories Inc., Tekni-Plex Inc., Pall Corporation, Zeus Company Inc., Watson-Marlow Ltd., Raumedic AG, Qosina, Optinova AB, ESI Ultrapure

North America was the largest region in the biopharmaceutical tubing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical tubing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the biopharmaceutical tubing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biopharmaceutical tubing market consists of sales of polytetrafluoroethylene (PTFE) tubing, ethylene-vinyl acetate (EVA) tubing, and rubber tubing. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biopharmaceutical Tubing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biopharmaceutical tubing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biopharmaceutical tubing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biopharmaceutical tubing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Silicone Tubing; Polyvinyl Chloride (PVC) Tubing; Polyolefin Tubing; Thermoplastic Elastomer Tubing
  • 2) By Manufacturing Process: Extrusion; Vulcanization; Other Manufacturing Processes
  • 3) By Application: Pharmaceutical; Medical Devices; Research And Development; Other Applications
  • Subsegments:
  • 1) By Silicone Tubing: Medical-Grade Silicone Tubing; Platinum-Cured Silicone Tubing; Peroxide-Cured Silicone Tubing
  • 2) By Polyvinyl Chloride (Pvc) Tubing: Clear Pvc Tubing; Non-Dehp Pvc Tubing; Soft Pvc Tubing
  • 3) By Polyolefin Tubing: Cross-Linked Polyolefin Tubing; Low-Density Polyethylene Tubing; High-DDensity Polyethylene Tubing
  • 4) By Thermoplastic Elastomer Tubing: Medical-Grade Tpe Tubing; Elastomeric Tpe Tubing; Biocompatible Tpe Tubing
  • Companies Mentioned: Compagnie de Saint-Gobain S.A.; Thermo Fisher Scientific Inc.; Merck KGaA; GE HealthCare Technologies Inc.; Parker Hannifin Corporation; DuPont de Nemours Inc.; Freudenberg Group; Medline Industries LP; Avantor Inc.; Alfa Laval AB; REHAU Group; W. L. Gore & Associates Inc.; Sartorius AG; Elkem ASA; Trelleborg AB; Bio-Rad Laboratories Inc.; Tekni-Plex Inc.; Pall Corporation; Zeus Company Inc.; Watson-Marlow Ltd.; Raumedic AG; Qosina; Optinova AB; ESI Ultrapure
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Biopharmaceutical Tubing Market Characteristics

3. Biopharmaceutical Tubing Market Trends And Strategies

4. Biopharmaceutical Tubing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Biopharmaceutical Tubing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Biopharmaceutical Tubing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Biopharmaceutical Tubing Market Growth Rate Analysis
  • 5.4. Global Biopharmaceutical Tubing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Biopharmaceutical Tubing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Biopharmaceutical Tubing Total Addressable Market (TAM)

6. Biopharmaceutical Tubing Market Segmentation

  • 6.1. Global Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Silicone Tubing
  • Polyvinyl Chloride (PVC) Tubing
  • Polyolefin Tubing
  • Thermoplastic Elastomer Tubing
  • 6.2. Global Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Extrusion
  • Vulcanization
  • Other Manufacturing Processes
  • 6.3. Global Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmaceutical
  • Medical Devices
  • Research And Development
  • Other Applications
  • 6.4. Global Biopharmaceutical Tubing Market, Sub-Segmentation Of Silicone Tubing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Medical-Grade Silicone Tubing
  • Platinum-Cured Silicone Tubing
  • Peroxide-Cured Silicone Tubing
  • 6.5. Global Biopharmaceutical Tubing Market, Sub-Segmentation Of Polyvinyl Chloride (PVC) Tubing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Clear PVC Tubing
  • Non-Dehp PVC Tubing
  • Soft PVC Tubing
  • 6.6. Global Biopharmaceutical Tubing Market, Sub-Segmentation Of Polyolefin Tubing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cross-Linked Polyolefin Tubing
  • Low-Density Polyethylene Tubing
  • High-Density Polyethylene Tubing
  • 6.7. Global Biopharmaceutical Tubing Market, Sub-Segmentation Of Thermoplastic Elastomer Tubing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Medical-Grade TPE Tubing
  • Elastomeric TPE Tubing
  • Biocompatible TPE Tubing

7. Biopharmaceutical Tubing Market Regional And Country Analysis

  • 7.1. Global Biopharmaceutical Tubing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Biopharmaceutical Tubing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Biopharmaceutical Tubing Market

  • 8.1. Asia-Pacific Biopharmaceutical Tubing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Biopharmaceutical Tubing Market

  • 9.1. China Biopharmaceutical Tubing Market Overview
  • 9.2. China Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Biopharmaceutical Tubing Market

  • 10.1. India Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Biopharmaceutical Tubing Market

  • 11.1. Japan Biopharmaceutical Tubing Market Overview
  • 11.2. Japan Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Biopharmaceutical Tubing Market

  • 12.1. Australia Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Biopharmaceutical Tubing Market

  • 13.1. Indonesia Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Biopharmaceutical Tubing Market

  • 14.1. South Korea Biopharmaceutical Tubing Market Overview
  • 14.2. South Korea Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Biopharmaceutical Tubing Market

  • 15.1. Western Europe Biopharmaceutical Tubing Market Overview
  • 15.2. Western Europe Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Biopharmaceutical Tubing Market

  • 16.1. UK Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Biopharmaceutical Tubing Market

  • 17.1. Germany Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Biopharmaceutical Tubing Market

  • 18.1. France Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Biopharmaceutical Tubing Market

  • 19.1. Italy Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Biopharmaceutical Tubing Market

  • 20.1. Spain Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Biopharmaceutical Tubing Market

  • 21.1. Eastern Europe Biopharmaceutical Tubing Market Overview
  • 21.2. Eastern Europe Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Biopharmaceutical Tubing Market

  • 22.1. Russia Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Biopharmaceutical Tubing Market

  • 23.1. North America Biopharmaceutical Tubing Market Overview
  • 23.2. North America Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Biopharmaceutical Tubing Market

  • 24.1. USA Biopharmaceutical Tubing Market Overview
  • 24.2. USA Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Biopharmaceutical Tubing Market

  • 25.1. Canada Biopharmaceutical Tubing Market Overview
  • 25.2. Canada Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Biopharmaceutical Tubing Market

  • 26.1. South America Biopharmaceutical Tubing Market Overview
  • 26.2. South America Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Biopharmaceutical Tubing Market

  • 27.1. Brazil Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Biopharmaceutical Tubing Market

  • 28.1. Middle East Biopharmaceutical Tubing Market Overview
  • 28.2. Middle East Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Biopharmaceutical Tubing Market

  • 29.1. Africa Biopharmaceutical Tubing Market Overview
  • 29.2. Africa Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Biopharmaceutical Tubing Market Competitive Landscape And Company Profiles

  • 30.1. Biopharmaceutical Tubing Market Competitive Landscape
  • 30.2. Biopharmaceutical Tubing Market Company Profiles
    • 30.2.1. Compagnie de Saint-Gobain S.A. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. GE HealthCare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Parker Hannifin Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Biopharmaceutical Tubing Market Other Major And Innovative Companies

  • 31.1. DuPont de Nemours Inc.
  • 31.2. Freudenberg Group
  • 31.3. Medline Industries LP
  • 31.4. Avantor Inc.
  • 31.5. Alfa Laval AB
  • 31.6. REHAU Group
  • 31.7. W. L. Gore & Associates Inc.
  • 31.8. Sartorius AG
  • 31.9. Elkem ASA
  • 31.10. Trelleborg AB
  • 31.11. Bio-Rad Laboratories Inc.
  • 31.12. Tekni-Plex Inc.
  • 31.13. Pall Corporation
  • 31.14. Zeus Company Inc.
  • 31.15. Watson-Marlow Ltd.

32. Global Biopharmaceutical Tubing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Biopharmaceutical Tubing Market

34. Recent Developments In The Biopharmaceutical Tubing Market

35. Biopharmaceutical Tubing Market High Potential Countries, Segments and Strategies

  • 35.1 Biopharmaceutical Tubing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Biopharmaceutical Tubing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Biopharmaceutical Tubing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer